Associated Papers
The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A1-A2A receptor heteromer formation and function.
Sarasola LI et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2022
Cancer-related somatic mutations alter adenosine A1 receptor pharmacology-A focus on mutations in the loops and C-terminus.
Wang X et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2022
Thermal Unfolding of the Human Serotonin Transporter: Differential Effect by Stabilizing and Destabilizing Mutations and Cholesterol on Thermodynamic and Kinetic Stability.
Ponleitner M et al.
Molecular Pharmacology, 2022
Functional Impact of the G279S Substitution in the Adenosine A1-Receptor (A1R-G279S7.44), a Mutation Associated with Parkinson's Disease.
Nasrollahi-Shirazi S et al.
Molecular Pharmacology, 2020
PTRHD1 and possibly ADORA1 mutations contribute to Parkinsonism with intellectual disability.
Elahi E
Movement Disorders : Official Journal of the Movement Disorder Society, 2018
ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies.
Blauwendraat C et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2017
Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction.
Jaberi E et al.
Movement Disorders : Official Journal of the Movement Disorder Society, 2016
Select a paper to view details